Objective Linkage disequilibrium (LD) and recombination rate variations are known to vary considerably between human genome regions and populations mostly because of the combined effects of mutation, recombination, and demographic history. Thus, the pattern of LD is a key issue to disentangle variants associated with complex traits. Here, we aim to describe the haplotype structure and LD variation at the pharmacogenetically relevant cytochrome P450 CYP2C and CYP2D gene regions among European populations.
Objective Linkage disequilibrium (LD) and recombination rate variations are known to vary considerably between human genome regions and populations mostly because of the combined effects of mutation, recombination, and demographic history. Thus, the pattern of LD is a key issue to disentangle variants associated with complex traits. Here, we aim to describe the haplotype structure and LD variation at the pharmacogenetically relevant cytochrome P450 CYP2C and CYP2D gene regions among European populations.
Methods To assess the haplotype structure, LD pattern, and recombination rate variations in the clinically significant CYP2C and CYP2D regions, we genotyped 143 single-nucleotide polymorphisms (SNPs) across these two genome regions in a diverse set of 11 European population samples and one sub-Saharan African sample.
Results Our results showed extended patterns of LD and in general a low rate of recombination at these loci, and a low degree of allele differentiation for the two cytochrome P450 regions among Europeans, with the exception of the Sami and the Finns as European outliers. The Sami sample showed reduced haplotype diversity and higher LD for the two cytochrome P450 regions than the other Europeans, a feature that is proposed to enhance the LD mapping of underlying common complex traits. However, recombination hotspots and LD blocks at these two regions showed highly consistent structures across Europeans including Finns and Sami. Moreover, we showed that the CEPH sample has significantly higher tag transferability among Europeans and a more efficient tagging of both the rare CYP2C9 and the common CYP2C19 functional variants than the Sami. Our data set included CYP2C9*3 (rs1057910) and CYP2C19*2 (rs4244285) enzyme activityaltering variants associated in a recent genome-wide study with acenocoumarol-induced and warfarin-induced anticoagulation or to the antiplatelet effect of clopidogrel, respectively. Including these known activity-altering variants, we showed the haplotype variation and high derived allele frequencies of novel recently identified acenocoumarol genome-wide associated SNPs at CYP2C9 (rs4086116) and CYP2C18 (rs12772169, rs1998591, rs2104543, rs1042194) loci in a comprehensive set of 11 European populations. Furthermore, a significant frequency difference of a CYP2C19*2 gene mutation causing variable drug reactions was observed among Europeans.
Conclusion
The CEPH sample representing the general European population as such in the HapMap project seems to be the optimal population sample for the LD mapping of common complex traits among Europeans. Nevertheless, it is still argued that the unique pattern of LD in the Sami may offer an advantage for further association mapping, especially if multiple rare variants play a role in disease etiology. However, besides the activity-altering CYP2C9*3 (rs1057910) and CYP2C19*2 (rs4244285) variants, the high derived allele frequencies of novel recently identified acenocoumarol genome-wide associated SNPs at CYP2C9 (rs4086116) and CYP2C18 (rs12772169, rs1998591, rs2104543, rs1042194) loci variants indicated that the CYP2C region may have been influenced by selection. Thus, this fine-scale haplotype map of the CYP2C and CYP2D regions may help to choose markers for further association mapping of complex pharmacogenetic traits at these loci. particularly on characterizing the underlying haplotype structures of clinically significant cytochrome P450 (CYP) genes [1] [2] [3] [4] [5] [6] . To date, most of the human CYP variants described are variations associated with monogenically determined drug reactions (e.g. CYP2C9 and warfarin; CYP2C19 and clopidogrel; CYP2D6 and tamoxifen) [5] . However, most pharmacogenetic traits are complex, with several genes and variants affecting drug metabolism and response [7] . Association mapping [i.e. linkage disequilibrium (LD) mapping] has been proposed to be a feasible tool for finding genetic factors involved in common complex traits by assuming that the disease-causing variant is linked for a certain amount of time with markers in its physical vicinity and that the disease etiology is influenced to a nontrivial degree by a single common variant in a given gene region [8, 9] . However, finding an association between a phenotype and a marker depends largely on the distribution of LD in the populations studied, and LD is known to vary considerably between genome regions and populations. Therefore, a solid understanding of the haplotype structure and LD distribution at drug-metabolizing enzyme loci in several human populations is important for association studies of variation in drug effects determined by the interaction of multiple genes [7] [8] [9] .
Two CYP2 gene subfamily regions, CYP2C [10] at 10q24 and CYP2D [11] at 22q13.1, contribute considerably toward clinically important drug responses [5] . The CYP2C region contains genes that encode CYP2C8, CYP2C9, CYP2C18, and CYP2C19 enzymes. The CYP2D region contains the gene encoding the CYP2D6 enzyme as well as the CYP2D7 and CYP2D8 pseudogenes. At least three of these drug-metabolizing enzymes (CYP2C9, CYP2C19, and CYP2D6) play a crucial role in the metabolic pathways of endogenous and exogenous natural substrates [12] . Furthermore, clinically important drugs such as antidepressors, neuroleptics, b-blockers, antiarrhythmics, vitamin K antagonistic anticoagulants, antidiabetic drugs, proton pump inhibitors, and anti-inflammatory agents are almost exclusively metabolized by these enzymes [5, 12] .
To assess the haplotype structure, LD pattern, and recombination rate variation in clinically significant cytochrome P450 CYP2C and CYP2D regions, we genotyped altogether 143 single-nucleotide polymorphisms (SNPs) across these two genome regions in a diverse set of 11 European population samples and one African sample. These data allowed us to disentangle the complex European haplotype structures at the CYP2C and CYP2D subfamily regions. Our study found extended patterns of LD and in general a low rate of recombination at these loci. We also observed a highly consistent recombination hotspot and LD block structure among Europeans. Moreover, we found a significant frequency difference among Europeans in a protein activity-altering mutation of CYP2C19*2 relevant in drug metabolism and response. These results may not only be clinically significant but also valuable for further attempts at mapping complex pharmacogenetic traits.
Materials and methods

Participants
We assayed a total of 811 DNAs from unrelated and ethnically self-identified individuals who provided informed consent and not selected for disease, recruited from 11 European-populations and one sub-Saharan African Mandenka (man, n = 56) group. Population samples recruited from Europe included British (bri, n = 77), Orcadians (orc, n = 88), Catalans (cat, n = 66), Italians from Bergamo (ber, n = 82 men), from Piedmont (pie, n = 59), and from Sicily (sic, n = 59), French Basques (bas, n = 76), Finns (fin, n = 71), Roma from Spain (rom, n = 62), Sami from the Kola peninsula (saa, n = 49), and individuals from the CEPH northern and western European reference families (cep, n = 66).
Genotypes
A total of 55 common SNPs in the CYP2C region and 97 SNPs in the CYP2D region were genotyped at the Centre National de Genotypage, Evry, France, using the IlluminaBeadarray Platform (Illumina, San Diego, California, USA) [13] . All the SNPs were chosen with a minor allele frequency (MAF) of at least 0.05 in dbSNP and a mean spacing of 7.8 and 7.6 kb for the CYP2C (B400 kb) and CYP2D (B702 kb) regions, respectively. Genotype data were loaded into a database within the SNPator web server (http://bioinformatica.cegen.upf.es) [14] , and further quality control tests were carried out. Fifty SNPs in the CYP2C and 93 at the CYP2D regions showed at least a 98.5% genotyping call rate for all populations and MAF of at least 0.05 in at least nine of the 11 European populations and were retained for further analysis (Supplementary 
Analysis of extended linkage disequilibrium regions
Metric LD maps [20] expressed in linkage disequilibrium units (LDUs) were constructed for both genome regions using diplotype and haplotype data from all 12 populations. LD blocks were identified by combining adjacent intervals with widths less than 0.3 LDUs and a recombination hotspot was called with widths more than 1.0 LDU [21] . The Haploview program v.4.0 was also used to identify LD blocks within both regions [22] . In this case, the block definition by Gabriel et al. [23] was used as a standard estimate, and four gamete [24] and solid spine [22] estimates of LD blocks were also carried out.
In a more detailed analysis of LD, all pairwise SNP combinations were tested in each population by estimating |D 0 | and r 2 from phased genotypes using Arlequin v3.0 [15] . The significance of pairwise LD determinations was tested using w 2 with a Bonferroni correction for multiple testing [25] . To represent the differential decay of LD within the extended LD regions, we plotted the r 2 values against the intermarker distances (NCBI Build 36.3) and computed the logarithmic best-fit curves for each population sample. To assess the significant difference in the r 2 pattern for adjacent SNPs within the extended LD regions among the populations, a Wilcoxon's test was applied using SPSS 17.0 (IBM). The network of inferred common haplotypes (MAF Z 0.05) within the CYP2C extended LD region was constructed using program Network v.4.500 (Fluxus Technology Ltd, Suffolk, UK) and the median-joining algorithm with weight 1 assumed in all loci, except the eight highfrequency derived allele loci (Supplementary Table 1, http://links.lww.com/FPC/A516) and rs1998591 with weight 25 [26] . A correspondence analysis for shared common haplotypes between populations was carried out using Statistica (StatSoft, Tulsa, Oklahoma, USA).
TagSNP analysis
To verify the transferability of tags across populations, we selected tagSNPs within CEPH and Sami populations (considered as a general European model-population and isolate-population, respectively) and measured their performance in all other population samples. The pairwise algorithm of the Tagger program (http://www.broad.mit.edu/ mpg/haploview) [22] was used to select the tagSNPs and an r 2 of 0.8 was selected as a threshold for all analyses. Performance was defined as the number of SNPs in the evaluated population that had an r 2 of more than 0.8 with the tagSNPs over the total number of SNPs available. Thus, we also tested the efficiency of the selected tagSNPs to capture the observed common and rare CYP2C19*2 and CYP2C9*3 functional P450 variants observed in this study, respectively.
Results
Allele frequency differences
Derived allele frequencies of 50 and 93 SNPs covering the CYP2C and CYP2D subfamily regions are shown in Supplementary Table 1, http://links.lww.com/FPC/A516 and Table 2 , http://links.lww.com/FPC/A517, respectively. None of the informative SNP loci deviated significantly from Hardy-Weinberg equilibrium in any of the populations. The average F ST value across both regions together for all 12 populations was 0.036 (95% CI 0.025-0.047), whereas the corresponding value only among the Europeans was 0.018 (95% CI 0.014-0.022).
Pairwise F ST values showed that the sub-Saharan Mandenka population was clearly an outlier compared with all the European populations (Fig. 1 ). The Sami (F ST = 0.030-0.053; P < 0.001) and the Finns (F ST = 0.021-0.037; P < 0.001) were also significantly different from all other European and from each other (Fig. 1) . Moreover, the Basque, the Roma, and the Orcadian showed genetic differentiation from general Europeans by being significantly different from nine out of 10 European populations in this study (Fig. 1 ).
In contrast, using only the CYP2C region data, the Sami (F ST = 0.037-0.095; P < 0.01) and to some extent the Basque, the Roma, and the Orcadian were significantly different from other Europeans ( Supplementary Fig. 1A , http://links.lww.com/FPC/A515), whereas within the CYP2D region, only the Sami (0.015-0.039; P < 0.05) and the Finns (F ST = 0.029-0.047; P < 0.01) were significantly different from other Europeans ( Supplementary Fig. 1B , http://links.lww.com/FPC/A515).
European populations: R1 in the CYP2C region (Fig. 2a) , and R2 and R3 in the CYP2D region (Fig. 3a) . Moreover, differing fluctuations in recombination rate medians among the populations were observed in both regions. However, only the R1-R3 positions were proposed as recombination hotspots as only at these sites the population-specific recombination rate estimates showed significantly more than a 10-fold increase compared with the recombination rate mean of all European populations across each region. The Spearman rank correlation for the similarity between recombination rate estimates for Europeans was B20% higher for the CYP2D region, but mostly significant for both regions (Supplementary Table 3 , http://links.lww.com/ FPC/A518). The correlation between population F ST distances and recombination rate correlations for both regions together was positive and significant for all 12 populations (r = 0.57; P < 0.01) and also without the subSaharan Mandenka population (r = 0.65; P < 0.001). However, when the two regions were analyzed separately, only the CYP2D region F ST and recombination rate correlation was positive and significant (r = 0.4; P < 0.02), whereas for the CYP2C region, the correlation was negative and nonsignificant among Europeans (r = -0.12; P = 0.72).
Metric LD maps either from diploid (Figs 2b and c and 3b and c) or from haploid (Supplementary Fig. 2A and B, http://links.lww.com/FPC/A515) data show consistent LDU patterns of steps and plateaus within both regions. Recombination hotspots defined as an adjacent interval of LDU widths more than 1.0 show identical locations, with hotspots R1-R3 identified using recombination rate estimates (Figs 2a and c and 3a and c). Moreover, extended high LD regions were observed and only defined by one block (i.e. adjacent interval of LDU widths <0.3) in the CYP2C (379.3 kb, defined by 46 SNPs from rs11638 to rs2185570) and in the CYP2D (303.7 kb, defined by 46
SNPs from rs5751194 to rs134901) regions among all populations (Figs 2c and 3c, respectively; see also the corresponding Table 1 ). A more stringent criterion for LD blocks (i.e. adjacent intervals with LDU widths equal to zero) showed that the longest single LD block (362.5 kb) within the CYP2C region was for Sami and Italians from Sicily, whereas most other populations had a recombination step between CYP2C19 and CYP2C9 genes (Figs 2c and 4a, Table 1, see Supplementary Table 1 , http:// links.lww.com/FPC/A516 for gene locations). Within the CYP2D region, all the populations had a recombination step either at the 3 0 end of the CYP2D6 gene or within an intronic region of the TCF20 gene (Table 1; see  Supplementary Table 2 , http://links.lww.com/FPC/A517 for gene locations). The LD blocks, on the basis of the definition by Gabriel et al. [23] for each European population, are plotted in Fig. 4a and b . As for the metric LD maps, most of the CYP2C region was covered by Haploview LD blocks with a consistent size and location across populations, whereas the CYP2D region showed less LD and more heterogeneity of the existing blocks among the populations. However, clear extended LD regions were observed and defined by 1-3 blocks in the CYP2C (246 kb) and 2-4 blocks in the CYP2D (323 kb) regions for each population (slashed bars, Fig. 4a and b) .
Pairwise LD measures estimated for each European population within the extended LD CYP2C (379.3 kb, between rs11638 and rs2185570) and CYP2D region (303.7 kb, between rs5751194 and rs134901) showed a similar pattern of the lower proportion of significantly high LD (r 2 > 0.8; P < 0.05) in the CEPH sample and the highest in the Sami (Supplementary Table 4 , http://links.lww.com/FPC/A519). Clearly, the lowest level of LD was observed in the subSaharan African Mandenka population for both regions (Supplementary Table 4 , http://links.lww.com/FPC/A519).
The decay of r 2 with physical distance between all SNP pairs of extended LD showed the highest level and the slowest decay of LD in Sami for both the CYP2C region and within the first 100 kb interval for the CYP2D region ( Supplementary Fig. 3 , http://links.lww.com/FPC/A515). Thus, the only European population with a significantly different pattern of adjacent marker r 2 with respect to all the others in both regions was the Sami (Supplementary  Table 5 , http://links.lww.com/FPC/A515). However, for both regions, there were considerable heterogeneities in adjacent marker r 2 patterns among the Europeans.
Haplotypes within the extended linkage disequilibrium region
In total, 63 and 133 haplotypes were estimated for the CYP2C (B379.3 kb) and CYP2D (B303.7 kb) extended LD regions, respectively. However, only eight and 10 extended LD region common haplotypes were present at a frequency of at least 5% in at least one European population for the CYP2C and CYP2D regions, respectively Neighbor-Joining tree of population pairwise F ST distances between 12 studied populations using all 143 SNPs across the CYP2C and the CYP2D regions. SNPs, single-nucleotide polymorphisms.
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(Supplementary Table 6A , http://links.lww.com/FPC/A521 and Table 6B , http://links.lww.com/FPC/A522). These common haplotypes described 94% and 84% of the total observed European variation in the CYP2C and CYP2D extended LD regions, respectively (Supplementary Supplementary Fig. 4 , http://links.lww.com/FPC/A515). Phylogenetic relationships within the CYP2C extended LD region were examined for all common (MAF Z 0.05) haplotypes, showing a highly similar network topology between CYP2C region data ( Supplementary Fig. 5 , http://links.lww.com/FPC/A515) and the CYP2C9 gene variation reported by Veenstra et al. [3] .
CYP2C locus-altered activity and genome-wide associated variants
Considering CYP2C9 and CYP2C19 enzymes, individuals can be classified as extensive, intermediate, and poor metabolizers (PM). Extensive metabolizers are homozygous for the wild-type allele (i.e. CYP2C9*1 or CYP2C19*1), intermediate metabolizers have one wildtype and one altered activity allele (e.g. CYP2C9*3 or CYP2C19*2), and PM carry two copies of the altered activity variants. The CYP2C9*2,*3 and CYP2C19*2 variants are considered to determine the principal altered functional Recombination rate estimates and LD across the CYP2D region. (a) Recombination rate estimates inferred using the Phase v2.1 program. The y-axis is expressed in log-scaled units of recombination rate (4Nr). The dashed lines represent the upper and lower 95% confidence intervals of the 10-fold recombination rate medians among the European populations. R2-3 show the recombination hotspots identified. (b) Metric LD map using diploid data and expressed in linkage disequilibrium unit as described by Maniatis et al. [20] for the CYP2D region. (c) Metric LD map using diploid data and expressed in adjacent intervals of LDU widths. Population abbreviations are: Basque (bas), Bergamo (ber), British (bri), Catalan (cat), CEPH (cep), Finland (fin), Orcadian (orc), Piedmont (pie), Roma (rom), Sami (saa), Sicily (sic), and Mandenka (man). LD, linkage disequilibrium; LDU, linkage disequilibrium units.
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substitutions with clinical significance prevalent among Europeans (see also http://www.imm.ki.se/CYPalleles) [27] [28] [29] . Our data set included functional SNPs rs1057910 and rs4244285 for CYP2C9*3 C -42614 and CYP2C19*2 A -19154 variant alleles, respectively ( Table 2, see further Supplementary Table 1 , http://links.lww.com/FPC/A516). In addition, to search for evidence of a selective sweep involving chromosomes with the CYP2C19*2 A -19154 allele, we constructed a plot of extended haplotype homozygosity for ancestral (G) and derived (A) alleles among the European populations using unphased genotypes ( Supplementary  Fig. 6 , http://links.lww.com/FPC/A515). In our data, the average homozygous tract length in A/A-19154 homozygotes (n = 29) was 385.8 kb compared with 136.8 kb in G/G-19154 homozygotes (n = 523). In addition, our data set included variants associated in a recent genome-wide study to acenocoumarol dosage variation [30] : one for CYP2C9 (rs4086116) and four for the CYP2C18 gene region (rs1998591, rs2104543, rs12772169, rs1042194). All of these genome-wide association (GWA) variants (except rs2104543) showed high derived allele frequencies (Z 0.8) in most of our population samples.
TagSNP analysis
The numbers of tagSNPs estimated for each population to capture the underlying haplotype structure for both regions are shown in Table 3 . The Sami sample showed the lowest of only 12 tagSNPs for the CYP2C region, whereas the CEPH sample required 20 tags for full haplotype coverage (Table 3) . Similarly, the Sami and the Finns showed the lowest number of tagSNPs required for the CYP2D region, whereas the other European populations required more than 40 tagSNPs to capture the underlying genetic diversity (Table 3) . A more detailed measure of the CEPH and Sami tagSNP performance across other European populations for both regions is also shown in Table 3 . The 20 CYP2C region tagSNPs estimated for the CEPH sample showed a success rate of at least 0.9 in all other populations, whereas the 12 Sami tagSNPs captured the haplotype structure in other populations with a significantly lower rate between 0.52 and 0.74 (Table 3) . A similar trend was observed in the CYP2D region: the 41 CEPH tagSNPs showed a success rate of at least 0.9 in all other European populations, whereas the 38 Sami tagSNPs showed a significantly lower success rate in most other Europeans (Table 3) . Furthermore, the 20 CEPH tagSNPs captured both the rare CYP2C9*3 and the common CYP2C19*2 functional P450 variant allele (rs1057910 and rs4244285, respectively) in all European populations, but the 12 Sami tagSNPs captured only the common functional variant in eight other European populations.
Discussion Allele frequency differences
The genetic landscape in Europe has been characterized by relatively short genetic distances between populations [31] . Similarly, several pharmacogenetically relevant genes including CYP2C9, CYP2C19, and CYP2D6 and their functional variants have shown little variation among Europeans [27, 32, 33] . Our combined CYP2C and CYP2D data of Europeans and the Mandenka population from Africa showed a similar average range of genetic distance (B0.04) as observed by Heath et al. [34] in a large wholegenome SNP study of European, African, and Asian HapMap populations. Using only the European populations, our data showed, however, a 10-fold higher average F ST value compared with that obtained by Heath et al. [34] . However, when our outlier populations (i.e. the Sami, the Finns, the Basque, the Roma, and the Orcadian) were excluded from the analysis, we observed a similar average F ST value of 0.0031 (95% CI 0.0016-0.0045) as obtained by Heath et al. [34] among Europeans.
Moreover, our data indicated that the genetic distance between the Sami or the Finns and any other European population is on average 10-fold larger than in general between European populations [34] . For Europeans including the CEPH sample representing the general European population as such in the HapMap project, the locus-specific and population pairwise F ST values observed indicated a low degree of allele frequency differentiation (F ST range of 0.0016-0.0045) for the two cytochrome P450 regions. These results were in agreement with previous analyses of European populations, including the Sami and the Finns [31, 34, 35] . Interestingly, however, eight and 12 derived allele SNPs with high frequencies (> 0.8) in at least two populations were observed for the CYP2C and CYP2D regions, respectively (Supplementary Table 1 , http://links.lww.com/FPC/A516 and Table 2 , http://links.lww.com/FPC/A517). This may indicate discrepancies in the human chimpanzee ancestral allele assignments or evolutionary selection pressures that have increased particular SNP frequencies. LD block defined as adjacent intervals with LDU widths equal to zero [21] .
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Recombination hotspots and linkage disequilibrium
The estimated patterns of recombination rate variation for the CYP2C and CYP2D regions showed significant but lower correlation (r s < 0.75; Supplementary Table 3, http:/ /links.lww.com/FPC/A518) within Europe compared with correlations between continental groups observed by Evans and Cardon [36] using data from chromosome 20 (r s > 0.8). It is noteworthy that despite the allele frequency differences between the Sami or the Finns and any other European population and lower level recombination rate correlations among Europeans, the location and magnitude of detected hotspots were conserved in all Europeans including the Sami and Finns and also in the sub-Saharan Mandenka population (Figs 2-4) . The CEPH European reference sample had both a very similar recombination and LDU profile to other European populations (Figs 2 and 3 and Supplementary Table 3 , http://links.lww.com/FPC/A518). Hence, a fine-scale recombination map inferred from the CEPH data might be applicable for other European populations as well. The SNPs with lower recombination rates showed more variation in the rates between populations, however, indicating among-population differences either in recombination histories or in past demography.
The haplotype structure at the CYP2C region has been shown to be conserved across populations in our data (Fig. 2, Supplementary Fig. 4A http://links.lww.com/FPC/ A515, Supplementary Table 6A http://links.lww.com/FPC/ A521) and in previous studies [2, 4, 6] . Indeed, the pattern of recombination rate variation and adjacent marker r 2 values in the CYP2C region in the CEPH sample were highly similar to those of the other Europeans (Fig. 2 Figs 2 and 4a) . Congruent results were obtained with all block criteria and with MAFs greater than 0.05 and 0.1 ( Supplementary Fig. 7A , http://links.lww.com/FPC/ A515), despite the fact that the LD block structure at CYP2C region has remained under debate [2, 4] . However, the low proportion of high LD for the CEPH in contrast to the high proportion of high LD for Sami and the significantly different pattern of adjacent marker r 2 values indicated differences for the population-specific haplotypes spanning the CYP2C region.
Within the CYP2D extended LD region, most of the European populations showed significantly different patterns of adjacent marker r 2 values and still showed a highly congruent LD block and recombination hotspot structure across Europeans (Table 1, Figs 3 and 4b and Supplementary Fig. 7B , http://links.lww.com/FPC/A515). Analogous to the CYP2C region, the Sami showed the largest proportion of high LD and a significantly different pattern of adjacent marker r 2 values in CYP2D among Europeans. However, using the more stringent LD block criteria (Table 1 , see also Fig. 3) , the Sami were the only population to show both CYP2D extended LD block region recombination steps common among Europeans (data not shown). The decay of LD was rather similar between the populations for the two regions showing the slowest decay for the Sami and more similar rates among the other Europeans ( Supplementary Fig. 3 , http:// links.lww.com/FPC/A515). However, some heterogeneity in the adjacent marker r 2 values at CYP2D region was observed across populations (Supplementary Table 5 , http://links.lww.com/FPC/A520, see also The lowest estimated number of CYP2C and CYP2D haplotypes was observed for the Sami (Supplementary  Table 4 , http://links.lww.com/FPC/A519), but with high and low haplotype diversity, respectively, compared with most other Europeans. This fluctuation is not surprising as the unique genetic diversity and LD pattern among Sami can be attributed to past demographic and evolutionary factors. First, genetic drift is shown to generate enhanced but random LD patterns [37, 38] . Second, the high but fluctuating LD for Sami could be linked to the small effective population size with a constant size and subsequent long-term drift increasing the LD in Sami compared with other European populations [35, [39] [40] . In addition, the positive and significant correlation between recombination profiles and F ST values for CYP2D region or both regions combined was expected as differences in the recombination rates between populations often increase with their genetic distance [41] . However, the CYP2C region showed a negative and nonsignificant correlation, which might also indicate that genetic selection has acted on the region. The above-described features such as reduced haplotype diversity and high extended LD among the Sami, and also observed by Terwilliger et al. [37] and Kaessman et al. [39] , strongly indicated that not the CEPH sample but the Sami could be the optimal population for the LD-based drift mapping of complex pharmacogenetic traits across the CYP2C and CYP2D regions.
Haplotype diversity and CYP2C region-altered activity variants
The CYP2C9*3 allele had a frequency of less than 10% and C -42614 homozygotic individuals were almost absent in European samples (Table 2) . Similar values have been reported in other studies within Europe [29, 42] . Most of the CYP2C19 PM genotypes (> 95%) [25, 26] in the context of Europe are inferred using the CYP2C19*2 A -19154 variant (Table 2) . Our data showed 10-20% A -19154 allele frequencies across most of the European populations, which is congruent with the earlier observed 13.4-16.0% (95% CI, N = 3990) allele frequency distribution within Europe [27] . The Sami showed the highest observed A -19154 allele frequency (37.8%) and CYP2C19*2 A -19154 homozygosity of 0.143 (95% CI 0.073-0.212), with a significant difference (P < 0.05) from most European samples (Table 2 ; see also Xie et al. [27] ). In fact, the Sami showed the highest CYP2C19*2 A -19154 allele frequency in Europe reported so far [27] . Similar high CYP2C19*2 A -19154 frequencies (Z 0.30) have been observed in Asian populations [28, [43] [44] [45] [46] [47] , and thus, the Asian origin for the high CYP2C19*2A -19154 allele frequency among Sami could be argued, but a more likely explanation is simply long-term drift. Interestingly, the rare CYP2C9*3 and common CYP2C19*2 altered activity haplotypes showed less derived alleles (four to eight sites) across the CYP2C extended LD region than that observed in other common haplotypes (10-15 sites) (Supplementary Table 6A , http://links.lww. com/FPC/A521). The genotype data for the CYP2C region also showed a consistently longer average homozygous tract length for the activity-altering CYP2C19*2 (A) homozygotes compared with the wild-type CYP2C19*1 (G) homozygotes. The specific distribution and diversity of the CYP2C19 activity-altering allele may thus indicate that the CYP2C region has been influenced by selection. However, a more detailed analysis with full-sequence CYP2C region data is required to confirm the role of selection.
To test the superior feasibility of the reduced haplotype diversity and high extended LD of the Sami sample among Europeans to capture the underlying functional CYP2C variants, we estimated the tagSNPs for each population. As expected, the Sami required less tagSNPs than most other European samples such as the CEPH for full haplotype coverage for both regions (Table 3) . However, tagSNPs of the CEPH sample showed a significantly higher success rate for tag transferability than the Sami tagSNPs. Moreover, the CEPH tagSNPs captured both the rare CYP2C9 and the common CYP2C19 functional variants in all European populations, whereas the Sami tagSNPs captured only the more common CYP2C19 variant in eight other populations. These results indicated clearly that the CEPH [48] sample-based tagSNPs could be after all the optimal markers for the LD mapping of complex traits among Europeans across the studied cytochrome P450 regions and further across other genomic regions as proposed by Montpetit et al. [48] and Huyghe et al. [35] . However, the reduced haplotype diversity and high LD of the Sami could still facilitate a gene association, although with lower tagSNP resolution, especially if multiple rare variants play a role in disease etiology [35] .
Since the establishment of pharmacogenomics, there has been an intense theoretical debate over the superiority of either the candidate gene or the GWA approach in the analyses on drug response [49] . Today, however, several GWA studies on drug response have shown their value with significant associations to variants within the CYP2C9 [30] and CYP2C19 [30, 50] , although so far not within the CYP2D6 gene [49] . However, these GWA studies have merely provided confirmation of earlier candidate gene results rather than novel new data. In this context, our study disentangled the novel distribution of CYP2C9*3 (rs1057910) and CYP2C19*2 (rs4244285) variants previously GWA associated with acenocoumarolinduced and warfarin-induced anticoagulation [30, [51] [52] or associated with the antiplatelet effect of clopidogrel, respectively (Supplementary Table 6A , http://links.lww.com/ FPC/A521) [50] . Moreover, we showed the haplotype variation and LD pattern of novel recently identified acenocoumarol GWA-associated SNPs [30] located at CYP2C9 (rs4086116) and CYP2C18 (rs12772169, CYP2C and CYP2D haplotype diversity Pimenoff et al. 855 rs1998591, rs2104543, rs1042194) loci in a comprehensive set of 11 European populations and one African population (Supplementary Table 6A , http://links.lww.com/FPC/A521).
